NeoGenomics Reports $7.5 Million Loss for Third Quarter
The diagnostics company reported a 6-cent-per-share loss, impacting how operators evaluate fiscal stability in the sector.
Live Poll
Does a company beating earnings estimates make you more confident in the current stock market?